Table 3.
First Author | Comparison Made | Surgical Technique | Definition of Supratotal | Volume Assessment | Adjuvant Therapy | Follow-up Time | Outcomes Measured |
---|---|---|---|---|---|---|---|
Eyüpoglu et al (2016)36 | DiVA vs Control for supra-complete resection | Dual intraoperative Visualization Approach (DiVA): iMRI with integrated functional navigation and 5-ALA, using an iterative approach. | Beyond both vague and distinct 5-ALA borders and confirmed with iMRI | MRI: T1-weighted MPRAGE 3D, T2, DWI, and BOLD functional with iPlan Cranial Software. Postop assessment at time of operation end. | Radio- chemotherapy with temozolomide. | Up to 44 mo (med: 18.5 mo) | KPS; OS; Neurological deficits |
Pessina et al (2017)39 | Supratotal vs gross total vs subtotal vs biopsy-only | Maximal removal of the tumor mass according to functional boundaries. Use of intraoperative neuro-navigation and ultrasound. Resection extended in select cases only if no new neurological deficits identified by cortical and subcortical stimulation. | 100% of enhanced and FLAIR resection. | MRI: T1, Enhanced, FLAIR; postop <48 h after surgery. | Concurrent and adjuvant chemo- radiotherapy. | 4.0–86.5 mo (med: 13.8 mo) | Adjuvant treatment; KPS; PFS; OS; postop morbidity and toxicity. |
Abbreviations: BOLD, blood oxygenation level dependent; DWI, diffusion-weighted imaging; MPRAGE, magnetization-prepared rapid acquisition with gradient echo.